Sign inJoin waitlistJoin the waitlist

Nisha Unni

Associate Professor in the Department of Internal Medicine · UT Southwestern Medical Center

Credentials: · · · · ·

History

UT Southwestern Medical Center
Present

UMDNJ-Robert Wood Johnson Medical School
2010–2013
Yale New Haven Hospital
2009–2010
Saint Vincent Hospital
2006–2009
Trivandrum Medical College, India
1997–2003
University of Medicine and Dentistry of New Jersey – Robert Wood Johnson Medical School

Research

LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
Nature · 2018 · 259 citations
The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer
Review · Cancers · 2020 · 105 citations
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
Annals of Oncology · 2023 · 58 citations

Carlos Arteaga
8 papers
Samira Syed
5 papers
Basak Dogan
4 papers
Deborah Farr
4 papers
KJ
Komal Jhaveri
4 papers
Navid Sadeghi
4 papers
Chika Nwachukwu
3 papers
HL
Hsiao-Ching Li
3 papers
AB
Adam Brufsky
2 papers
Asal Rahimi
2 papers
BH
Barbara Haley
2 papers
Berat Ozcan
2 papers · 1 as a resident

Clinical trials

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
2018–2025
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2033
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Site PI · Recruiting · Phase 1
NiKang Therapeutics, Inc.
2025–2027
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Site PI · Recruiting · Phase 2
Vanderbilt-Ingram Cancer Center
2024–2031